Zengwei Kou

Zengwei Kou


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YZYue Zeng
Yue Zeng
YZYueming Zheng
Yueming Zheng
TZTongtong Zhang
Tongtong Zhang
FYFei Ye
Fei Ye
LZLi Zhan
Li Zhan
ZGZhaobing Gao
Zhaobing Gao
N-methyl-D-aspartate receptors (NMDARs) are Ca2+-permeable ionotropic glutamate receptors (iGluRs) in the central nervous system and play important roles in neuronal development and synaptic plasticity. Conventional NMDARs, which typically comprise GluN1 and GluN2 subunits, have different biophysical properties than GluN3-containing NMDARs: GluN3-containing NMDARs have smaller unitary conductance, less Ca2+-permeability and lower Mg2+-sensitivity than those of conventional NMDARs. However, there are very few specific modulators for GluN3-containing NMDARs. Here, we developed a cell-based high-throughput calcium assay and identified 3-fluoro-1,2-phenylene bis (3-hydroxybenzoate) (WZB117) as a relatively selective inhibitor of GluN1/GluN3 receptors. The IC50 value of WZB117 on GluN1/GluN3A receptors expressed in HEK-293 cells was 1.15 ± 0.34 μM. Consistently, WZB117 exhibited strong inhibitory activity against glycine-induced currents in the presence of CGP-78608 but only slightly affected the NMDA-, KA- and AMPA-induced currents in the acutely isolated rat hippocampal neurons. Among the four types of endogenous currents, only the first one is primarily mediated by GluN1/GluN3 receptors. Mechanistic studies showed that WZB117 inhibited the GluN1/GluN3A receptors in a glycine-, voltage- and pH-independent manner, suggesting it is an allosteric modulator. Site-directed mutagenesis and chimera construction further revealed that WZB117 may act on the GluN3A pre-M1 region with key determinants different from those of previously identified modulators. Together, our study developed an efficient method to discover modulators of GluN3-containing NMDARs and characterized WZB117 as a novel allosteric inhibitor of GluN1/GluN3 receptors.

16 April 2025 in Channels
Verified
Journal Article
Open access
KXKunlong Xiong
Kunlong Xiong
SLShulei Lou
Shulei Lou
ZLZuoyu Lian
Zuoyu Lian
YWYunlin Wu
Yunlin Wu
ZKZengwei Kou
Zengwei Kou
N-methyl-D-aspartate receptors (NMDARs) are heterotetrameric ion channels that play crucial roles in brain function. Among all the NMDAR subtypes, GluN1-N3 receptors exhibit unique agonist binding and gating properties. Unlike "conventional" GluN1-N2 receptors, which require both glycine and glutamate for activation, GluN1-N3 receptors are activated solely by glycine. Furthermore, GluN1-N3 receptors display faster desensitization, reduced Ca2+ permeability, and lower sensitivity to Mg2+ blockage compared to GluN1-N2 receptors. Due to these characteristics, GluN1-N3 receptors are thought to play critical roles in eliminating redundant synapses and pruning spines in early stages of brain development. Recent studies have advanced pharmacological tools for specifically targeting GluN1-N3 receptors and provided direct evidence of these glycine-activated excitatory receptors in native brain tissue. The structural basis of GluN1-N3 receptors has also been elucidated through cryo-EM and artificial intelligence. These findings highlight that GluN1-N3 receptors are not only involved in essential brain functions but also present potential targets for drug development.

6 June 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YLYunsheng Liu
Yunsheng Liu
YJYanyan Jia
Yanyan Jia
ZKZengwei Kou
Zengwei Kou
NMDA receptors, a subtype of ionotropic glutamate receptors, play pivotal roles in the brain by mediating synaptic signal transduction, facilitating intercellular communication, and shaping neural circuits, thereby serving as molecular switches for learning and memory. Since its discovery and isolation in the 1960s, NMDA receptors have remained a focal point of research in neuroscience. The past decade has witnessed a large number of high-quality studies on the biophysical properties, three-dimensional structure, and pathophysiological functions of NMDA receptors. In this study, we employed bibliometric methods to analyze publications from 2015 to 2024, visualizing research hotspots, trends, and key milestones of NMDA receptors. Additionally, we also identified the leading researchers, institutions, and countries that contributed to this area. Our findings provide a comprehensive overview of recent NMDA receptor research, which will help readers understand the trends and influence in this field.

20 August 2024 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
YLYunsheng Liu
Yunsheng Liu
DSDa Shao
Da Shao
SLShulei Lou
Shulei Lou
ZKZengwei Kou
Zengwei Kou
N-methyl-D-aspartate (NMDA) receptors are heterotetrametric ion channels composed of two obligatory GluN1 subunits and two alternative GluN2 or GluN3 subunits, forming GluN1-N2, GluN1-N3, and GluN1-N2-N3 type of NMDA receptors. Extensive research has focused on the functional and structural properties of conventional GluN1–GluN2 NMDA receptors due to their early discovery and high expression levels. However, the knowledge of unconventional GluN1-N3 NMDA receptors remains limited. In this study, we modeled the GluN1-N3A, GluN1-N3B, and GluN1-N3A-N3B NMDA receptors using deep-learned protein-language predication algorithms AlphaFold and RoseTTAFold All-Atom. We then compared these structures with GluN1-N2 and GluN1-N3A receptor cryo-EM structures and found that GluN1-N3 receptors have distinct properties in subunit arrangement, domain swap, and domain interaction. Furthermore, we predicted the agonist- or antagonist-bound structures, highlighting the key molecular–residue interactions. Our findings shed new light on the structural and functional diversity of NMDA receptors and provide a new direction for drug development. This study uses advanced AI algorithms to model GluN1-N3 NMDA receptors, revealing unique structural properties and interactions compared to conventional GluN1-N2 receptors. By highlighting key molecular–residue interactions and predicting ligand-bound structures, our research enhances the understanding of NMDA receptor diversity and offers new insights for targeted drug development.

11 September 2025 in Biological Psychiatry Global Open Science
Verified
Journal Article
Open access
YLYunsheng Liu
Yunsheng Liu
ZKZengwei Kou
Zengwei Kou
Treatment-resistant depression (TRD) remains a major psychiatric challenge, with therapeutic paradigms evolving over the last 50 years. However, research on TRD is fragmented across molecular mechanisms, clinical interventions, and epidemiological trends, highlighting the need for a comprehensive synthesis to guide future studies and enhance clinical outcomes. We conducted a large-scale bibliometric analysis of 16,198 TRD-related publications from PubMed, Web of Science, and Scopus (1974–2025). Using CiteSpace, VOSviewer, and Bibliometrix, we quantified publication trends, collaborative networks, and thematic shifts. Special attention was paid to influential researchers and institutions, as well as examining the shifting research focus from traditional invasive therapies, including deep brain stimulation, to emerging pharmacological advancements such as ketamine-based treatments. We identified leading countries, institutions, and key contributors on TRD research. Thematic clusters revealed sustained focus on neurobiological mechanisms (glutamate dysfunction, inflammation) and clinical efficacy. A pivotal shift from invasive techniques (dominant before 2000) to ketamine-based therapies was observed, with ketamine-related publications surging after 2010. High-impact journals such as Biological Psychiatry and American Journal of Psychiatry anchored 3 intellectual clusters: molecular neuropharmacology, pathophysiology, and clinical psychiatry. Despite progress, gaps persist in understanding ketamine’s systemic effects and noncanonical NMDA receptor roles. This bibliometric study traces TRD research evolution from the 1970s onward, revealing key shifts from invasive interventions to novel pharmacotherapies such as ketamine, a transformative advance highlighting a mechanism-driven approach. By analyzing influential contributors, collaborations, and emerging trends, our work synthesizes decades of fragmented knowledge, providing clinicians and researchers with a cohesive road map for future TRD investigations.

23 August 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
YLYunsheng Liu
Yunsheng Liu
RZRongde Zhong
Rongde Zhong
YLYao-Xuan Li
Yao-Xuan Li
CYChengjian Yu
Chengjian Yu
JZJin-fang Zhang
Jin-fang Zhang
ZKZengwei Kou
Zengwei Kou